| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |